All In MedTech

FDA Clearance Tracker · P040042-S009

SAFIRE TX CARDIAC ABLATION CATHETER AND INTERFACE CABLES

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Aug 21, 2007 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Aug 21, 2007

Approved

Time to decision

162 days

Received Mar 12, 2007. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track

Device class

Class III

The decision

FDA number
P040042-S009
Device name
SAFIRE TX CARDIAC ABLATION CATHETER AND INTERFACE CABLES
Applicant location
Irvine, CA
Received
Mar 12, 2007
Decided
Aug 21, 2007
Decision
Approved
Supplement type
Normal 180 Day Track
Reason for supplement
Change Design/Components/Specifications/Material
Original approval
P040042

Device type

Device class
Class III

Every decision under product code OAD

FDA's approval statement

As written in FDA's record.

APPROVAL FOR THE SAFIRE TX CARDIAC ABLATION CATHETER MODEL 1642 AND THE MODELS 1740-SW AND 1779-SE INTERFACE CABLES.

Source documents

Other decisions for Irvine Biomedical,Inc.(Ibi)

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

No other decisions since 2015 under this exact applicant name.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.